Multiplex blood-test and Magnetic Resonance Imaging (MRI) for prostate cancer screening: Results from the 2nd screening round in the STHLM3-MRI trial

被引：0
|
作者：
Discacciati, A. [1 ]
Abbadi, A. [1 ]
Chandra, J. [2 ]
Annerstedt, M. [3 ]
Glaessgen, A. [4 ]
Carlsson, S. [5 ]
Jaderling, F. [5 ]
Gronberg, H. [1 ]
Eklund, M. [1 ]
Nordstrom, T. [1 ]
机构：
[1] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden
[2] Karolinska Inst, Dept Clin Sci, Danderyd Hosp, Stockholm, Sweden
[3] Dept Urol, C Med, Stockholm, Sweden
[4] Unilabs, Dept Pathol, Stockholm, Sweden
[5] Karolinska Inst, Dept Mol Med, Stockholm, Sweden
来源：
EUROPEAN UROLOGY | 2024年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0664
引用
收藏
页码：S1611 / S1611
页数：1
相关论文
共 40 条
  • [21] MRI-targeted biopsies in prostate cancer screening and the value of its combination with blood-based risk-prediction: The randomized, diagnostic study STHLM3MRI
    Nordstrom, Tobias
    Discacciati, Andrea
    Jaderling, Fredrik
    Karlsson, Stefan Gosta
    Aly, Markus
    Gronberg, Henrik
    Eklund, Martin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [22] The GoTEBORG prostate cancer screening 2 trial: a prospective, randomised, population-based prostate cancer screening trial with prostate-specific antigen testing followed by magnetic resonance imaging of the prostate
    Kohestani, Kimia
    Mansson, Marianne
    Godtman, Rebecka Arnsrud
    Stranne, Johan
    Wallstrom, Jonas
    Carlsson, Sigrid
    Hellstrom, Mikael
    Hugosson, Jonas
    SCANDINAVIAN JOURNAL OF UROLOGY, 2021, 55 (02) : 116 - 124
  • [23] INTENSIFIED MRI-BASED PROSTATE CANCER SCREENING IN GERMLINE CARRIERS OF RARE PATHOGENIC VARIANTS: INTERIM RESULTS FROM THE INITIAL SCREENING ROUND OF THE PROGRESS STUDY
    Andrew, Amini
    Alexandra, Hunter
    Aya, Almashad
    Aileen, Feng J.
    Neel, Patel D.
    Shelley, McCormick R.
    Linda, Rodgers H.
    Keyan, Salmi
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S91 - S91
  • [24] Magnetic resonance imaging in oesophageal (oes) cancer: Results from the STO3 MRI substudy
    Davidson, M.
    Nankivell, M.
    Cunningham, D.
    Starling, N.
    Koh, D-M.
    Brown, G.
    Allum, W.
    Wotherspoon, A.
    Smyth, E.
    Ly, L.
    Kleovoulou, N.
    Langley, R.
    Riddell, A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [25] Design of a magnetic resonance imaging-based screening program for early diagnosis of prostate cancer: preliminary results of a randomized controlled trial-Prostate Cancer Secondary Screening in Sapienza (PROSA)
    Messina, Emanuele
    La Torre, Giuseppe
    Pecoraro, Martina
    Pisciotti, Martina Lucia
    Sciarra, Alessandro
    Poscia, Roberto
    Catalano, Carlo
    Panebianco, Valeria
    EUROPEAN RADIOLOGY, 2024, 34 (01) : 204 - 213
  • [26] Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: Results from the International Breast Magnetic Resonance Consortium (IBMC) Trial
    Lehman, CD
    Blume, JD
    Thickman, D
    Bluemke, DA
    Pisano, E
    Kuhl, C
    Julian, TB
    Hylton, N
    Weatherall, P
    O'Loughlin, M
    Schnitt, SJ
    Gatsonis, C
    Schnall, MD
    JOURNAL OF SURGICAL ONCOLOGY, 2005, 92 (01) : 9 - 15
  • [27] Re: Matthias Boschheidgen, Peter Albers, Heinz-Peter Schlemmer, et al. Multiparametric Magnetic Resonance Imaging in Prostate Cancer Screening at the Age of 45 Years: Results from the First Screening Round of the PROBASE Trial
    Ortegon, Jose D. Cardona
    Perilla, Laura A. Campana
    Bermudez, Laura M. Olarte
    EUROPEAN UROLOGY, 2024, 86 (01)
  • [28] MAGNETIC RESONANCE IMAGING-BASED PROSTATE CANCER SCREENING: DIFFERENCES IN THE COSTEFFECTIVENESS USING EVIDENCE FROM DIAGNOSTIC COHORTS VERSUS SCREENING-BY-INVITATION TRIAL
    Hao, S.
    Clements, M. S.
    VALUE IN HEALTH, 2022, 25 (12) : S67 - S67
  • [29] Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: Results from the International Breast Magnetic Resonance Consortium (IBMC) Trial - Commentary
    Bland, KI
    JOURNAL OF SURGICAL ONCOLOGY, 2005, 92 (01) : 15 - 16
  • [30] Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRI
    Nordstrom, Tobias
    Jaderling, Fredrik
    Carlsson, Stefan
    Aly, Markus
    Gronberg, Henrik
    Eklund, Martin
    BMJ OPEN, 2019, 9 (06):
1234